Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 14.90B | $ 14.73B | $ 13.60B | $ 11.87B | $ 15.79B |
Total Assets | $ 157.44B | $ 153.95B | $ 154.10B | $ 155.06B | $ 156.86B |
Total Debt | $ 75.58B | $ 67.18B | $ 69.52B | $ 66.80B | $ 68.82B |
Net Debt | $ 60.69B | $ 52.45B | $ 55.92B | $ 54.92B | $ 53.03B |
Total Liabilities | $ 99.70B | $ 96.98B | $ 96.05B | $ 97.25B | $ 97.28B |
Stockholders Equity | $ 55.45B | $ 54.69B | $ 55.89B | $ 55.80B | $ 58.36B |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |